Rhizen Pharmaceuticals (Switzerland)

Recent papers from Rhizen Pharmaceuticals (Switzerland)

1. S-allyl cysteine suppresses lipopolysaccharide-induced microglial inflammation accompanied by attenuation of JNK1/2 and STAT3 signalingNutritional Neuroscience · 2026
2. Oxylipin KODA enhances the early growth of rice (Oryza sativa L.) under low-temperature stress at night to simulate a natural temperature conditionPlant Biotechnology · 2025
3. Bioconversion and Metabolic Fate of the n-1 Polyunsaturated Fatty Acids, 6,9,12,15- Hexadecatetraenoic (C16:4 n-1) and 8,11,14,17- Octadecatetraenoic (C18:4 n-1) Acids, in HepG2 CellsJournal of Oleo Science · 2025
4. Safety and efficacy of tenalisib in combination with romidepsin in patients with relapsed/refractory T-cell lymphoma: results from a phase I/II open-label multicenter studyHaematologica · 2023
5. Sunvozertinib, a Selective EGFR Inhibitor for Previously Treated Non–Small Cell Lung Cancer with EGFR Exon 20 Insertion MutationsCancer Discovery · 2022
6. One-Year Clinical Trial of Olive Leaf ExtractJournal of Society of Cosmetic Chemists of Japan · 2021
7. Effect of 6,9,12,15-Hexadecatetraenoic Acid (C16:4n-1)-Ethyl Ester on Lipid Content and Fatty Acid Composition in the Blood and Organs of MiceJournal of Oleo Science · 2021
8. A first‐in‐human study to evaluate the safety, tolerability and pharmacokinetics of RP3128, an oral calcium release‐activated calcium (CRAC) channel modulator in healthy volunteersJournal of Clinical Pharmacy and Therapeutics · 2020
9. Phase I/Ib Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor in Patients with Relapsed/Refractory T-Cell LymphomaCancers · 2020
10. Calcium Release-Activated Calcium (CRAC) Channel Inhibition Suppresses Pancreatic Ductal Adenocarcinoma Cell Proliferation and Patient-Derived Tumor GrowthCancers · 2020
11. Blueberry Leaf Polyphenols Prevent Body Fat Accumulation in Mice Fed High-fat, High-sucrose DietJournal of Oleo Science · 2019
12. Targeting Cancer Cells and Tumor Microenvironment in Preclinical and Clinical Models of Hodgkin Lymphoma Using the Dual PI3Kδ/γ Inhibitor RP6530Clinical Cancer Research · 2018
13. Phase I/II evaluation of RV1001, a novel PI3Kδ inhibitor, in spontaneous canine lymphomaPLoS ONE · 2018
14. Effects of Bitter Melon (Momordica charantia) Juice Powder on Lipid Metabolism in RatsNIPPON SHOKUHIN KOGYO GAKKAISHI · 2018
15. A Dose Escalation Study of RP6530, a Novel Dual PI3K Delta/Gamma Inhibitor, in Patients with Relapsed/Refractory Hematologic MalignanciesBlood · 2015
16. Evaluation of the estrogenic activity of Indian medicinal plants in immature ratsAncient Science of Life · 2015
17. Blueberry (Vaccinium virgatum Aiton) Leaf Infusion Ameliorates Insulin Resistance in Mice Fed a High-fat, High-sucrose DietFood Science and Technology Research · 2015
18. Comparison of the PI3K-δ Inhibitors TGR1202 and GS-1101 in Inducing Cytotoxicity and Inhibiting Phosphorylation of Akt in CLL Cells in VitroBlood · 2012
19. Novel PI3K Inhibitors Demonstrated Marked Cytotoxicity in T Cell Lymphoma Models, Caused Apoptosis and Were Synergistic with A Novel Anti-CD20 Monoclonal Antibody Ublituximab in B Cell Lymphoma ModelsBlood · 2012
20. Complexing of Green Tea Catechins with Food Constituents and Degradation of the Complexes by Lactobacillus plantarumBioscience of Microbiota Food and Health · 2012